Section 122DA(2)(c) in The Drugs and Cosmetics Rules, 1945
(c)confirmatory clinical trials (Phase-III) on a new drug shall be made on the basis of the data emerging from Phase-II and where necessary, data emerging from Phase-I also, and shall be accompanied by a fee of twenty-five thousand rupees: